Eiger BioPharmaceuticals, Inc.·4

Nov 30, 2:26 PM ET

Mayer Eldon C. III 4

4 · Eiger BioPharmaceuticals, Inc. · Filed Nov 30, 2018

Insider Transaction Report

Form 4
Period: 2018-11-29
Transactions
  • Purchase

    Common Stock

    2018-11-29$10.21/sh+4,000$40,84025,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $10.00 to $10.37 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1 to this Form 4.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION